Compare
Translational Development Acquisition Corp. vs Newbury Street II Acquisition Corp vs Globa Terra Acquisition Corp vs Copley Acquisition Corp
| Latest fiscal year | Translational Development Acquisition Corp. TDAC | Newbury Street II Acquisition Corp NTWO | Globa Terra Acquisition Corp GTERA | Copley Acquisition Corp COPL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | n/a | n/a | n/a |
| Revenue growth (YoY) | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a |
| Net income | $6.36M | $6.62M | $2.88M | $4.13M |
| EPS (Diluted) | n/a | n/a | n/a | n/a |
| Operating cash flow | -$608.4K | -$464.7K | -$437.1K | -$469.0K |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | $29.8K | n/a | $0 | $0 |
| Total assets | $181.70M | $182.74M | $179.07M | $178.16M |
| Total liabilities | $6.58M | $6.18M | $1.21M | $5.41M |
| Shareholders' equity | -$6.54M | -$5.29M | -$519.4K | -$5.22M |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | n/a | n/a | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Translational Development Acquisition Corp. | Newbury Street II Acquisition Corp | Globa Terra Acquisition Corp | Copley Acquisition Corp |
|---|---|---|---|---|
| Latest | n/a | n/a | n/a | n/a |
| 1 year earlier | n/a | n/a | n/a | n/a |
| 2 years earlier | n/a | n/a | n/a | n/a |
| 3 years earlier | n/a | n/a | n/a | n/a |
| 4 years earlier | n/a | n/a | n/a | n/a |